Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 206

1.

[Comparison of clinical features between gastroesophageal reflux diseases with atypical and typical symptoms].

Men RT, Yi ZH, Yang ZB, Xiao Q, Yang L.

Sichuan Da Xue Xue Bao Yi Xue Ban. 2014 May;45(3):484-8. Chinese.

PMID:
24941824
2.

How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related?

de Bortoli N, Nacci A, Savarino E, Martinucci I, Bellini M, Fattori B, Ceccarelli L, Costa F, Mumolo MG, Ricchiuti A, Savarino V, Berrettini S, Marchi S.

World J Gastroenterol. 2012 Aug 28;18(32):4363-70. doi: 10.3748/wjg.v18.i32.4363.

3.

Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they?

de Bortoli N, Martinucci I, Savarino E, Bellini M, Bredenoord AJ, Franchi R, Bertani L, Furnari M, Savarino V, Blandizzi C, Marchi S.

Neurogastroenterol Motil. 2014 Jan;26(1):28-35. doi: 10.1111/nmo.12221. Epub 2013 Aug 29.

PMID:
23992024
4.

Evaluation of Gastroesophageal Reflux by Combined Multichannel Intraluminal Impedance and pH Monitoring and Esophageal Motility Patterns in Children with Esophageal Atresia.

Tong S, Mallitt KA, Krishnan U.

Eur J Pediatr Surg. 2016 Aug;26(4):322-31. doi: 10.1055/s-0035-1564715. Epub 2015 Oct 7.

PMID:
26445355
5.

Gastroesophageal reflux symptoms in typical and atypical GERD: roles of gastroesophageal acid refluxes and esophageal motility.

Patcharatrakul T, Gonlachanvit S.

J Gastroenterol Hepatol. 2014 Feb;29(2):284-90. doi: 10.1111/jgh.12347.

PMID:
23926926
6.

Nocturnal gastric acid breakthrough is not associated with night-time gastroesophageal reflux in GERD patients.

Weigt J, Kandulski A, Büsch F, Malfertheiner P.

Dig Dis. 2009;27(1):68-73. doi: 10.1159/000210107. Epub 2009 May 8.

PMID:
19439964
7.

Combined pH-impedance monitoring and high-resolution manometry of Japanese patients treated with proton-pump inhibitors for persistent symptoms of non-erosive reflux disease.

Yamashita H, Ashida K, Fukuchi T, Nagatani Y, Koga H, Senda K, Eguchi T, Ubukata S, Kawaguchi S, Ueda A, Tanaka T, Ohashi R, Ito D.

J Smooth Muscle Res. 2012;48(5-6):125-35.

8.

Combined esophageal multichannel intraluminal impedance and pH monitoring (MII -pH) in the diagnostics and treatment of gastroesophageal reflux disease and its complications.

Masiak W, Wallner G, Wallner J, Pedowski T, Solecki M.

Pol Przegl Chir. 2011 Sep;83(9):488-96. doi: 10.2478/v10035-011-0076-7.

PMID:
22166737
9.

Predictors of proton pump inhibitor failure in non-erosive reflux disease: A study with impedance-pH monitoring and high-resolution manometry.

Shi Y, Tan N, Zhang N, Xiong L, Peng S, Lin J, Chen M, Xiao Y.

Neurogastroenterol Motil. 2016 May;28(5):674-9. doi: 10.1111/nmo.12763. Epub 2016 Jan 14.

PMID:
26768192
10.

Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor?

Hemmink GJ, Bredenoord AJ, Weusten BL, Monkelbaan JF, Timmer R, Smout AJ.

Am J Gastroenterol. 2008 Oct;103(10):2446-53. doi: 10.1111/j.1572-0241.2008.02033.x. Epub 2008 Aug 5.

PMID:
18684197
11.

OP-13 REFLUX AND ESOPHAGEAL MOTILITY PATTERNS IN CHILDREN WITH ESOPHAGEAL ATRESIA.

Krishnan U, Tong S.

J Pediatr Gastroenterol Nutr. 2015 Oct;61(4):514-5. doi: 10.1097/01.mpg.0000472217.78797.ae.

PMID:
26439554
12.

Tailored therapy for the refractory GERD patients by combined multichannel intraluminal impedance-pH monitoring.

Xiao Y, Liang M, Peng S, Zhang N, Chen M.

J Gastroenterol Hepatol. 2016 Feb;31(2):350-4. doi: 10.1111/jgh.13049.

PMID:
26202002
13.

Reflux pattern and role of impedance-pH variables in predicting PPI response in patients with suspected GERD-related chronic cough.

Ribolsi M, Savarino E, De Bortoli N, Balestrieri P, Furnari M, Martinucci I, Casale M, Greco F, Salvinelli F, Savarino V, Marchi S, Cicala M.

Aliment Pharmacol Ther. 2014 Oct;40(8):966-73. doi: 10.1111/apt.12919. Epub 2014 Aug 11.

14.

Limited ability of the proton-pump inhibitor test to identify patients with gastroesophageal reflux disease.

Bytzer P, Jones R, Vakil N, Junghard O, Lind T, Wernersson B, Dent J.

Clin Gastroenterol Hepatol. 2012 Dec;10(12):1360-6. doi: 10.1016/j.cgh.2012.06.030. Epub 2012 Jul 17.

PMID:
22813439
15.

Clinically distinct characteristics in patients younger than 40 years old with non-cardiac chest pain.

Ko SY, Kim SI, Kim JH, Lee JH, Lee KJ, Hong SN, Lee SY, Sung IK, Park HS, Shim CS.

J Gastroenterol Hepatol. 2012 Sep;27(9):1484-9. doi: 10.1111/j.1440-1746.2012.07174.x.

PMID:
22554344
16.

Increasing body weight enhances prevalence and proximal extent of reflux in GERD patients 'on' and 'off' PPI therapy.

Blondeau K, Boecxstaens V, Van Oudenhove L, Farré R, Boeckxstaens G, Tack J.

Neurogastroenterol Motil. 2011 Aug;23(8):724-e327. doi: 10.1111/j.1365-2982.2011.01720.x. Epub 2011 Apr 28.

PMID:
21535319
17.

Reflux characteristics of 113 GERD patients with abnormal 24-h multichannel intraluminal impedance-pH tests.

Nian YY, Feng C, Jing FC, Wang XQ, Zhang J.

J Zhejiang Univ Sci B. 2015 Sep;16(9):805-10. doi: 10.1631/jzus.B1500027.

18.

[Diagnosis of gastroesophageal reflux disease: a systematic review].

Cho YK, Kim GH, Kim JH, Jung HY, Lee JS, Kim NY; Korean Society of Neurogastroenterology and Motility.

Korean J Gastroenterol. 2010 May;55(5):279-95. Review. Korean.

19.

Gastroesophageal reflux monitoring: pH (catheter and capsule) and impedance.

Hong SK, Vaezi MF.

Gastrointest Endosc Clin N Am. 2009 Jan;19(1):1-22, v. doi: 10.1016/j.giec.2008.12.009. Review.

PMID:
19232277
20.

Comparison of the degree of duodenogastroesophageal reflux and acid reflux between patients who failed to respond and those who were successfully treated with a proton pump inhibitor once daily.

Gasiorowska A, Navarro-Rodriguez T, Wendel C, Krupinski E, Perry ZH, Koenig K, Moty B, Powers J, Fass R.

Am J Gastroenterol. 2009 Aug;104(8):2005-13. doi: 10.1038/ajg.2009.240. Epub 2009 Jun 2.

PMID:
19491829

Supplemental Content

Support Center